Latest News

July 29, 2014
To make follow-up care more accessible, UC San Francisco and Walgreens are collaborating to launch the first program in the country that provides blood pressure testing at no charge to living kidney donors.
July 24, 2014
What: In 2006, more than 6,500 specialists in transplant medicine worldwide gathered for the first time in one location at the World Transplant Congress (WTC) in Boston. Eight years later, the WTC is convening again, this time in San Francisco.
May 08, 2014
UCSF Medical Center has the highest one-year survival rate in the nation, among institutions performing more than 20 adult lung transplants each year, according to data from the Scientific Registry of Transplant Recipients.
March 10, 2014
Organ-transplant recipients often reject donated organs, but a new, two-pronged strategy developed by UCSF researchers to specifically weaken immune responses that target transplanted tissue has shown promise.
September 23, 2013
The 14th World Congress of the International Pancreas and Islet Transplant Association will convene in Monterey, Calif., sponsored by the Transplantation Society and experts from UC San Francisco.
December 07, 2012
WHAT: Former UCSF transplant patient Alfonso Garcia, 18, has been selected as a rider on the Donate Life “Journeys of the Heart” float at the Tournament of Roses Parade in Pasadena, Calif., on January 1, 2013.  He will do so to honor his donor, George Becker, who died at age 22 in 2010. A likeness of Becker will be captured in a floragraph, which is a portrait made of flowers, on the same float in this annual, internationally televised event.
October 22, 2012
Most liver transplant candidates who died or were removed from the transplant list actually received one or more liver donation offers, according to a recent UCSF study.
October 01, 2012
A $750,000 gift from the John and Marcia Goldman Foundation is spurring a UCSF-led effort to create the first implantable artificial kidney for patients with kidney failure.
January 03, 2012
Children with a rare, life-threatening disease that is the most common cause of neonatal liver failure – biliary atresia – better tolerate liver transplants from their mothers than from their fathers, according to a UCSF-led study.
October 26, 2011
The California Institute for Quantitative Biosciences (QB3) has signed an agreement with the Johnson & Johnson Corporate Office of Science and Technology (COSAT) to fund University of California proof-of-concept research that brings innovative science to market.

Pages